LATEST NEWS   Government to review amendments to certain Acts over ECRL cable theft offences - Saifuddin Nasution | AKPS must be equipped with new technology at entry points to ensure top-level border control - Saifuddin Nasution | AKPS to recruit 200 MAF veterans starting first quarter of this year - Saifuddin Nasution | AKPS on the right track and performing excellently, receives full support from Home Ministry - Saifuddin Nasution | 

There are 29 news based on search keyword " bioeconomy"

Cuba Mulls Biotech, Pharma Partnership With Malaysia, Eyeing ASEAN Launchpad

KUALA LUMPUR, Nov 26 (Bernama) -- Cuba and Malaysia should forge deeper partnerships in biotechnology and pharmaceuticals, particularly in producing vaccines, including halal vaccines that would cater to the local demographics, Cuban Ambassador to Malaysia Florentino Batista Gonzalez said.

Malaysia, South Korea To Foster ESG Investments And Technological Collaborations

SEOUL, Nov 25 (Bernama) -- Malaysia and South Korea have reiterated their commitment to fostering an investment climate aligned with environmental, social, and governance (ESG) principles.

PM Anwar Arrives In Brazil For Official Visit, Malaysia G20 Guest Country

By M. Saraswathi

RIO DE JANEIRO (Brazil), Nov 17 (Bernama) -- Prime Minister Datuk Seri Anwar Ibrahim arrived in Brazil, South America’s largest country, from Lima, Peru, for his official visit and to attend the Group of 20 (G20) Summit 2024, where Malaysia is a guest country.

PM Anwar Arrives In Brazil For Official Visit, Malaysia G20 Guest Country

RIO DE JANEIRO (Brazil), Nov 17 (Bernama) -- Prime Minister Datuk Seri Anwar Ibrahim arrived in Brazil, South America’s largest country, from Lima, Peru, for his official visit and to attend the Group of 20 (G20) Summit 2024, where Malaysia is a guest country.

ALPS Global Aims To Raise US$100 Mln Via Nasdaq IPO

By Durratul Ain Ahmad Fuad

KUALA LUMPUR, Sept 15 (Bernama) – Integrated biotech group ALPS Global Holding Bhd, which is en route to a Nasdaq listing in the fourth quarter of 2024, aims to raise US$100 million to fund its expansion, clinical studies, and manufacturing plant.